R
Roche Holdings RHHBY
$55.39
Last close: March 6, 2026
1W
1M
3M
6M
1Y
3Y
5Y
Key indicators
Price
P/E 25
Cheap
Expensive
Net margin
23%
Low
High
Earnings growth
+30%
Low
High
Bars: against the 190 close companies.
Key indicators
When a figure has a bar, the marker places it among its peers, and the further right it sits, the more the figure beats the others. Green marks the best third, red the weakest and white anything in between. Some figures stay white wherever they sit, like price, pace or holding time, because neither side is better there.
Earnings release
The day the company publishes its quarterly accounts: revenue, profit, and often its outlook. The price sometimes moves sharply that day, in either direction. Over the long term, what matters is the trend of profits from one quarter to the next, not the reaction of the day.
Posts
No posts about RHHBY yet.
About Roche Holdings AG Basel American Depositary Shares
Roche is a Swiss healthcare group that makes prescription medicines, mainly for cancer, eye disease, immune and nerve conditions such as multiple sclerosis, and sells diagnostic tests and equipment. It earns money from drug sales, protected by patents, and from lab and hospital testing products.